1. ACOG Practice Bulletin No. 209: Obstetric Analgesia and Anesthesia. Obstet Gynecol. 2019; 133(3): e208-25.

2. Tita A.T.N., Andrews W.W. Diagnosis and management of clinical chorioamnionitis. Clin Perinatol. 2010; 37(2): 339-54.

3. Schmitz T., Sentilhes L., Lorthe E., Gallot D., Madar EL, Doret-Dion M., et al. [Preterm premature rupture of membranes: CNGOF Guidelines for clinical practice - Short version], Gynecol Obstet Fertil Senol. 2018; 46(12): 998 - 1003.

4. Conde-Agudelo A., Romero R., Jung E.J., Garcia Sanchez A.J. Management of clinical chorioamnionitis: an evidence-based approach [Internet], Vol. 223, American Journal of Obstetrics and Gynecology. Elsevier Inc.; 2020. 848 - 869 p.

5. Romero R., Chaemsaithong P., Korzeniewski S.J., Kusanovic J.P., Docheva N., Martinez-Varea A., et al. Clinical chorioamnionitis at term III: how well do clinical criteria perform in the identification of proven intra-amniotic infection? J Perinat Med. 2016; 44(1): 23 - 32.

6. Oh K.J., Kim S.M., Hong J.-S., Maymon E., Erez O., Panaitescu B., et al. Twenty-four percent of patients with clinical chorioamnionitis in pretenn gestations have no evidence of either culture-proven intraamniotic infection or intraamniotic inflammation. Am J Obstet Gynecol. 2017; 216(6): 604.e1 - 604.e11.

7. Kikhney J., von Schoning D., Steding I., Schulze J., Petrich A., Hiergeist A., et al. Is Ureaplasma spp. the leading causative agent of acute chorioamnionitis in women with pretenn birth? Clin Microbiol Infect. 2017; 23(2): 119.e1 - 119.e7.

8. Oh K.J., Romero R., Park J.Y., Hong J.-S., Yoon B.H. The earlier the gestational age, the greater the intensity of the intra-amniotic inflammatory response in women with pretenn premature rupture of membranes and amniotic fluid infection by Ureaplasma species. J Perinat Med. 2019; 47(5): 516-27.

9. Romero R., Gomez-Lopez N., Kusanovic J.P, Pacora P., Panaitescu B., Erez O., et al. Clinical Chorioamnionitis at Tenn: New Insights into the Etiology, Microbiology, and the Fetal, Maternal and Amniotic Cavity Inflammatory Responses. Nogyogy es szuleszeti Tovabbk Szle. 2018; 20(3): 103-12.

10. Sweeney E.L., Dando S.J., Kallapur S.G., Knox C.L. The human Ureaplasma species as causative agents of chorioamnionitis. Clin Microbiol Rev. 2017; 30(1): 349-79.

11. Combs C.A., Gravett M., Garite T.J., Hickok D.E., Lapidus J., Porreco R., et al. Amniotic fluid infection, inflammation, and colonization in preterm labor with intact membranes. Am J Obstet Gynecol. 2014; 210(2): 125.e1 - 125.e15.

12. Mendz G.L., Kaakoush N.O., Quinlivan J.A. Bacterial aetiological agents of intra-amniotic infections and pretenn birth in pregnant women. Front Cell Infect Microbiol. 2013; 3:58.

13. Oh K.J., Lee K.A., Sohn Y.-K., Park C.-W., Hong J.-S., Romero R., et al. Intraamniotic infection with genital mycoplasmas exhibits a more intense inflammatory response than intraamniotic infection with other microorganisms in patients with preterm premature rupture of membranes. Am J Obstet Gynecol. 2010; 203(3): 211.e1 - 8.

14. Krohn M.A., Hillier S.L., Nugent R.P., Cotch M.F., Carey J.C., Gibbs R.S., et al. The genital flora of women with intraamniotic infection. Vaginal Infection and Prematurity Study Group. J Infect Dis. 1995; 171(6): 1475-80.

15. Freud A., Wainstock T., Sheiner E., Beloosesky R., Fischer L., Landau D., et al. Maternal chorioamnionitis & long term neurological morbidity in the offspring. Eur J Paediatr Neurol EJPN Off J Eur Paediatr Neurol Soc. 2019; 23(3): 484-90.

16. Romero R., Gomez-Lopez N., Winters A.D., Jung E., Shaman M., Bieda J., et al. Evidence that intra-amniotic infections are often the result of an ascending invasion - a molecular microbiological study. J Perinat Med. 2019; 47(9): 915-31.

17. Kim M.J., Romero R., Gervasi M.T., Kim J.-S., Yoo W., Lee D.-C., et al. Widespread microbial invasion of the chorioamniotic membranes is a consequence and not a cause of intra-amniotic infection. Lab Invest. 2009; 89(8): 924-36.

18. Kim C., Romero R., Chaemsaithong P., Chaiyasit N., Yoon B., Kim Y. Acute Chorioamnionitis and Funisitis: Definition, Pathologic Features, and Clinical Significance. Am J Obstet Gynecol. 2015; 213: S29 - 52.

19. Sorano S., Goto M., Matsuoka S., Tohyama A., Yamamoto H., Nakamura S., et al. Chorioamnionitis caused by Staphylococcus aureus with intact membranes in a term pregnancy: A case of maternal and fetal septic shock. J Infect Chemother Off J Japan Soc Chemother. 2016; 22(4): 261-4.

20. Jadhav A.R., Belfort M.A., Dildy G.A. 3rd. Eikenella corrodens chorioamnionitis: modes of infection? Am J Obstet Gynecol. 2009; 200(5): e4 - 5.

21. Radochova V., Musilova I., Stepan M., Vescicik P., Slezak R., Jacobsson B., et al. Periodontal disease and intra-amniotic complications in women with preterm prelabor rupture of membranes. J Matem Neonatal Med. 2017; 31:1.

22. Tongsong T., Wanapirak C., Kunavikatikul C., Sirirchotiyakul S., Piyamongkol W., Chanprapaph P. Cordocentesis at 16 - 24 weeks of gestation: experience of 1,320 cases. Prenat Diagn. 2000; 20(3): 224-8.

23. Goldenberg R.L., Andrews W.W., Hauth J.C. Choriodecidual infection and preterm birth. Nutr Rev. 2002; 60(5 Pt2): S 19 - 25.

24. Fahey J.O. Clinical management of intra-amniotic infection and chorioamnionitis: a review of the literature. J Midwifery Womens Health. 2008; 53(3): 227-35.

25. Romero R., Chaemsaithong R., Korzeniewski S.J., Tarca A.L., Bhatti G., Xu Z., et al. Clinical chorioamnionitis at term II: The intra-amniotic inflammatory response. J Perinat Med. 2016; 44(1): 5 - 22.

26. Xing L., Wang G., Chen R., Ren J., Qian J., Huang Y. Is chorioamnionitis associated with neurodevelopmental outcomes in preterm infants? A systematic review and meta-analysis following PRISMA. Med (United States). 2019; 98(50).

27. Sato M., Nishimaki S., Yokota S., Seki K., Horiguchi H., An H., et al. Severity of chorioamnionitis and neonatal outcome. J Obstet Gynaecol Res. 2011; 37(10): 1313-9.

28. Soper D.E., Mayhall C.G., Dalton H.P Risk factors for intraamniotic infection: a prospective epidemiologic study. Am J Obstet Gynecol. 1989; 161(3): 562-8.

29. Newton E.R. Chorioamnionitis and intraamniotic infection. Clin Obstet Gynecol. 1993; 36(4): 795 - 808.

30. NEWTON E.D., PRIHODAT.J., GIBBS R.S. Logistic Regression Analysis of Risk Factors for Intra-Amniotic Infection. Obstet Gynecol. 1989; 73(4).

31. Piper J.M., Newton E.R., Berkus M.D., Peairs W.A. Meconium: a marker for peripartum infection. Obstet Gynecol. 1998; 91(5 Pt 1): 741-5.

32. Seaward P.G., Hannah M.E., Myhr T.L., Farine D., Ohlsson A., Wang E.E., et al. International Multicentre Term Prelabor Rupture of Membranes Study: evaluation of predictors of clinical chorioamnionitis and postpartum fever in patients with prelabor rupture of membranes at term. Am J Obstet Gynecol. 1997; 177(5): 1024-9.

33. Romero-Guzman G.J., Lopez-Munoz F. [Prevalence and risk factors for periventricular leukomalacia in pretenn infants. A systematic review]. Rev Neurol. 2017; 65(2): 57 - 62.

34. Rouse D.J., Landon M., Leveno K.J., Leindecker S., Vamer M.W., Caritis S.N., et al. The maternal-fetal medicine units cesarean registry: Chorioamnionitis at term and its duration - Relationship to outcomes. Am J Obstet Gynecol. 2004; 191(1): 211-6.

35. Randis T.M., Rice M.M., Myatt L., Tita A.T.N., Leveno K.J., Reddy U.M., et al. Incidence of early-onset sepsis in infants born to women with clinical chorioamnionitis. J Perinat Med. 2018; 46(8): 926-33.

36. Venkatesh K.K., Jackson W., Hughes B.L., Laughon M.M., Thorp J.M., Stamilio D.M. Association of chorioamnionitis and its duration with neonatal morbidity and mortality. J Perinatol. 2019; 39(5): 673-82.

37. Soraisham A.S., Singhal N., McMillan D.D., Sauve R.S., Lee S.K. A multicenter study on the clinical outcome of chorioamnionitis in preterm infants. Am J Obstet Gynecol. 2009; 200(4): 372.e1 - 6.

38. Klinger G., Levy I., Sirota L., Boyko V., Reichman B., Lemer-Geva L. Epidemiology and risk factors for early onset sepsis among very-low-birthweight infants. Am J Obstet Gynecol. 2009; 201(1): 38.e1 - 6.

39. Pappas A., Kendrick D.E., Shankaran S., Stoll B.J., Bell E.F., Laptook A.R., et al. Chorioamnionitis and early childhood outcomes among extremely low-gestational-age neonates. JAMA Pediatr. 2014; 168(2): 137-47.

40. Ericson J.E., Laughon M.M. Chorioamnionitis: implications for the neonate. Clin Perinatol. 2015; 42(1): 155-65, ix.

41. Gowda H., Norton R., White A., Kandasamy Y. Late-onset Neonatal Sepsis-A 10-year Review From North Queensland, Australia. Pediatr Infect Dis J. 2017; 36(9): 883-8.

42. Villamor-Martinez E., Alvarez-Fuente M., Ghazi A.M.T., Degraeuwe P., Zimmermann L.J.I., Kramer B.W., et al. Association of Chorioamnionitis With Bronchopulmonary Dysplasia Among Preterm Infants: A Systematic Review, Meta-analysis, and Metaregression. JAMANetw open. 2019; 2(11): e1914611.

43. Wang L.-W., Lin Y.-C., Wang S.-Т., Huang C.-C. Identifying Risk Factors Shared by Bronchopulmonary Dysplasia, Severe Retinopathy, and Cystic Periventricular Leukomalacia in Very Preterm Infants for Targeted Intervention. Neonatology. 2018; 114(1): 17 - 24.

44. Spiegel A.M., Li J., Oehlert J.W., Mayo J.A., Quaintance C.C., Girsen A.I., et al. A Genome-Wide Analysis of Clinical Chorioamnionitis among Preterm Infants. Am J Perinatol. 2019; 36(14): 1453-8.

45. Garcia-Munoz Rodrigo F., Galan Henriquez G.M., Ospina C.G. Morbidity and mortality among very-low-birth-weight infants bom to mothers with clinical chorioamnionitis. Pediatr Neonatol. 2014; 55(5): 381-6.

46. Seong H.S., Lee S.E., Kang J.H., Romero R., Yoon B.H. The frequency of microbial invasion of the amniotic cavity and histologic chorioamnionitis in women at term with intact membranes in the presence or absence of labor. Am J Obstet Gynecol. 2008; 199(4): 375.e1 - 5.

47. Racusin D.A., Chen H.-Y., Bhalwal A., Wiley R., Chauhan S.P Chorioamnionitis and adverse outcomes in low-risk pregnancies: a population-based study. J Matern neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet. 2021; :1 - 9.

48. Wu Y.W., Escobar G.J., Grether J.K., Croen L.A., Greene J.D., Newman T.B. Chorioamnionitis and cerebral palsy in term and near-term infants. JAMA. 2003; 290(20):2677-84.

49. Schmitz T., Sentilhes L., Lorthe E., Gallot D., Madar H., Doret-Dion M., et al. Management of clinical chorioamnionitis: an evidence-based approach. Crowther CA, editor. Am J Obstet Gynecol. 2017; 221(1): 1 - 6.

50. Xiao D., Zhu T., Qu Y., Gou X., Huang Q., Li X., et al. Maternal chorioamnionitis and neurodevelopmental outcomes in pretenn and very pretenn neonates: A meta-analysis. PLoS One. 2018; 13(12): e0208302.

51. Maisonneuve E., Ancel P.-Y., Foix-L'Helias L., Marret S., Kayem G. Impact of clinical and/or histological chorioamnionitis on neurodevelopmental outcomes in preterm infants: A literature review. J Gynecol Obstet Hum Reprod. 2017; 46(4): 307-16.

52. Vander Haar E., Gyamfi-Bannerman C. Chorioamnionitis and Neurocognitive Development at Age 2 Years. Obstet Gynecol. 2016; 127(3): 437-41.

53. Shi Z., Ma L., Luo K., Bajaj M., Chawla S., Natarajan G., et al. Chorioamnionitis in the Development of Cerebral Palsy: A Meta-analysis and Systematic Review. Pediatrics. 2017; 139(6).

54. Ylijoki M.K., Ekholm E., Ekblad M., Lehtonen L. Prenatal Risk Factors for Adverse Developmental Outcome in Preterm Infants-Systematic Review. Vol. 10, Frontiers in psychology. 2019. p. 595.

55. Bommarito K.M., Gross G.A., Willers D.M., Fraser V.J., Olsen M.A. The Effect of Clinical Chorioamnionitis on Cesarean Delivery in the United States. Health Serv Res. 2016; 51(5): 1879-95.

56. Perry A., Rossi R., Defranco E. Severe Adverse Maternal Outcomes Associated with Chorioamnionitis. Am J Obstet Gynecol MFM. 2019; 1.

57. Alexander J.M., McIntire D.M., Leveno K.J. Chorioamnionitis and the prognosis for term infants. Obstet Gynecol. 1999; 94(2): 274-8.

58. Blume H.K., Li C.I., Loch C.M., Koepsell T.D. Intrapartum fever and chorioamnionitis as risks for encephalopathy in term newborns: A case-control study. Dev Med Child Neurol. 2008; 50(1): 19 - 24.

59. Rouse D.J., Leindecker S., Landon M., Bloom S.L., Vamer M.W., Moawad A.H., et al. The MFMU Cesarean Registry: uterine atony after primary cesarean delivery. Am J Obstet Gynecol. 2005; 193(3 Pt 2): 1056-60.

60. Venkatesh K.K., Glover A.V., Vladutiu C.J., Stamilio D.M. Association of chorioamnionitis and its duration with adverse maternal outcomes by mode of delivery: a cohort study. BJOG. 2019; 126(6): 719-27.

61. Witlin A.G., Mercer B.M., Sibai B.M. Septic pelvic thrombophlebitis or refractory postpartum fever of undetermined etiology. J Matem Fetal Med. 1996; 5(6): 355-8.

62. Koh K.S., Chan F.H., Monfared A.H., Ledger W.J., Paul R.H. The changing perinatal and maternal outcome in chorioamnionitis. Obstet Gynecol. 1979; 53(6): 730-4.

63. Romero R., Kadar N., Vaisbuch E., Hassan S.S. Maternal death following cardiopulmonary collapse after delivery: amniotic fluid embolism or septic shock due to intrauterine infection? Am J Reprod Immunol. 2010; 64(2): 113-25.

64. Chebbo A., Tan S., Kassis C., Tamura L., Carlson R.W. Maternal Sepsis and Septic Shock. Crit Care Clin. 2016; 32(1): 119-35.

65. Hospital Sant Joan de Deu. Protocolo: Corioamnionitis o triple I. Hosp Clin Barcelona. 2020; (1): 1 - 7.

66. Gynecologists T. american college of obstetricians and. Intrapartum Management of Intraamniotic Infection. Obstet Gynecol. 2017; 130(2): e95 - 101.

67. Сидельникова В.М. С.Г.Т. Невынашивание беременности: руководство для практикующих врачей. Москва: ООО "Медицинское информационное агентство"; 2011.

68. Tita A.T.N., Andrews W.W. Diagnosis and management of clinical chorioamnionitis. Clin Perinatol. 2010; 37(2): 339-54.

69. Савельева Г.М., Сухих Г.Т. С.В.Н. Акушерство. Национальное руководство. 2018.

70. Savitz D.A., Terry J.W.J., Dole N., Thorp J.M.J., Siega-Riz A.M., Herring A.H. Comparison of pregnancy dating by last menstrual period, ultrasound scanning, and their combination. Am J Obstet Gynecol. 2002; 187(6): 1660-6.

71. Olesen A.W., Thomsen S.G. Prediction of delivery date by sonography in the first and second trimesters. Ultrasound Obstet Gynecol Off J Int Soc Ultrasound Obstet Gynecol. 2006; 28(3):292-7.

72. Committee Opinion No. 713: Antenatal Corticosteroid Therapy for Fetal Maturation. Obstet Gynecol. 2017; 130(2): e102-9.

73. ACOG Practice Bulletin No. 106: Intrapartum fetal heart rate monitoring: nomenclature, interpretation, and general management principles. Obstet Gynecol. 2009; 114(1): 192 - 202.

74. Johnson C.T., Farzin A., Burd I. Current management and long-term outcomes following chorioamnionitis. Obstet Gynecol Clin North Am. 2014; 41(4): 649-69.

75. Beucher G., Charlier C., Cazanave C. Diagnosis and management of intra-uterine infection: CNGOF Preterm Premature Rupture of Membranes Guidelines. Gynecol Obstet Fertil Senol. 2018; 46(12): 1054-67.

76. Tuuli M.G., Macones G.A., Roehl K.A., Odibo A.O., Cahill A.G. Risk factors for serious morbidity in term nonanomalous neonates. Am J Obstet Gynecol. 2015; 212(6): 799.e1 - 799.e7.

77. Alexander J.M., Mercer B.M., Miodovnik M., Thumau G.R., Goldenberg R.L., Das A.R, et al. The impact of digital cervical examination on expectantly managed preterm rupture of membranes. Am J Obstet Gynecol. 2000; 183(4): 1003-7.

78. NICE. Preterm labour and birth overview. Natl Inst Heal Care Excell. 2019; (August): 1 - 12.

79. Sepsis-NICE. 2020; (July 2016).

80. Olah K.S., Gee H. The prevention of preterm delivery-can we afford to continue to ignore the cervix? Br J Obstet Gynaecol. 1992; 99(4): 278-80.

81. Ting H.-S., Chin Р.-S., Yeo G.S.H., Kwek K. Comparison of bedside test kits for prediction of pretenn delivery: phosphorylated insulin-like growth factor binding protein-1 (pIGFBP-1) test and fetal fibronectin test. Ann Acad Med Singapore. 2007; 36(6): 399 - 402.

82. Ehsanipoor R.M., Swank M.L., Jwa S.C., Wing D.A., Tarabulsi G., Blakemore K.J. Placental -Microglobulin-1 in Vaginal Secretions of Women with Evidence of Preterm Labor. Am J Perinatol. 2016; 33(2): 208-13.

83. Alfirevic Z., Allen-Coward H., Molina F., Vinuesa C.P, Nicolaides K. Targeted therapy for threatened pretenn labor based on sonographic measurement of the cervical length: a randomized controlled trial. Ultrasound Obstet Gynecol. 2007; 29(1): 47 - 50.

84. Popowski T., Goffinet F., Maillard F., Schmitz T., Leroy S., Kayem G. Maternal markers for detecting early-onset neonatal infection and chorioamnionitis in cases of premature rupture of membranes at or after 34 weeks of gestation: a two-center prospective study. BMC Pregnancy Childbirth. 2011; 11:26.

85. Шмаков Р.Г., Баев О.Р, Пекарев О.Е., Пырегов А.В., Приходько А.М. П.С.В. Кесарево сечение. Показания, хирургическая техника, методы обезболивания: учебное пособие. ООО ИФП "Системные решения." 2014; :72.

86. Higgins R.D., Saade G., Polin R.A., Grobman W.A., Buhimschi I.A., Watterberg K., et al. Evaluation and Management of Women and Newborns With a Maternal Diagnosis of Chorioamnionitis: Summary of a Workshop. Vol. 127, Obstetrics and gynecology. 2016. p. 426-36.

87. Fishman S.G., Gelber S.E. Evidence for the clinical management of chorioamnionitis. Semin Fetal Neonatal Med. 2012; 17(1): 46 - 50.

88. Lyell D.J., Pullen K., Fuh K., Zamah A.M., Caughey A.B., Benitz W., et al. Daily compared with 8-hour gentamicin for the treatment of intrapartum chorioamnionitis: A randomized controlled trial. Obstet Gynecol. 2010; 115(2 PART 1): 344-9.

89. Chapman E., Reveiz L., Illanes E., Cosp X.B. Antibiotic regimens for management of intra-amniotic infection. Cochrane Database Syst Rev. 2014; 2014(12).

90. Edwards R.K., Duff P. Single additional dose postpartum therapy for women with chorioamnionitis. Obstet Gynecol. 2003; 102(5 Pt 1): 957-61.

91. Shanks A.L., Mehra S., Gross G., Colvin R., Harper L.M., Tuuli M.G. Treatment Utility of Postpartum Antibiotics in Chorioamnionitis Study. Am J Perinatol. 2016; 33(8): 732-7.

92. Alekwe L., Kuti O., Orji E., Ogunniyi S. Comparison of ceftriaxone versus triple drug regimen in the prevention of cesarean section infectious morbidities. J Matem Fetal Neonatal Med. 2008; 21: 638-42.

93. Tumquest M.A., How H.Y., Cook C.R., O'Rourke T.P, Cureton A.C., Spinnato J.A., et al. Chorioamnionitis: is continuation of antibiotic therapy necessary after cesarean section? Am J Obstet Gynecol. 1998; 179(5): 1261-6.

94. Ashwal E., Salman L., Tzur Y., Aviram A., Ben-Mayor Bashi T., Yogev Y., et al. Intrapartum fever and the risk for perinatal complications - the effect of fever duration and positive cultures. J Matem neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet. 2018; 31(11): 1418-25.

95. Liebennan E., Cohen A., Lang J., Frigoletto F., Goetzl L. Maternal intrapartum temperature elevation as a risk factor for cesarean delivery and assisted vaginal delivery. Am J Public Health. 1999; 89(4): 506-10.

96. Dior U.P, Kogan L., Eventov-Friedman S., Gil M., Bahar R., Ergaz Z., et al. Very High Intrapartum Fever in Term Pregnancies and Adverse Obstetric and Neonatal Outcomes. Neonatology. 2016; 109(1): 62-8.

97. Burgess A.P.H., Katz J.E., Moretti M., Lakhi N. Risk Factors for Intrapartum Fever in Term Gestations and Associated Maternal and Neonatal Sequelae. Gynecol Obstet Invest. 2017; 82(5): 508 - 16.

98. Wang C., Schroeder I., Cazales A., Kim R., Albert A., Elwood C., et al. Management of fever in labor after institution of a standardized order set at a maternity quaternary care center. Am J Obstet Gynecol. 2019; 221:687.

99. Lange E.M.S., Segal S., Pancaro C., Wong C.A., Grobman W.A., Russell G.B., et al. Association between Intrapartum Magnesium Administration and the Incidence of Maternal Fever: A Retrospective Cross-sectional Study. Anesthesiology. 2017; 127(6): 942-52.

100. Kasdorf E., Perlman J.M. Hyperthermia, inflammation, and perinatal brain injury. Pediatr Neurol. 2013; 49(1): 8 - 14.

101. Impey L.W.M., Greenwood C.E.L., Black R.S., Yeh PS.-Y., Sheil O., Doyle P. The relationship between intrapartum maternal fever and neonatal acidosis as risk factors for neonatal encephalopathy. Am J Obstet Gynecol. 2008; 198(1): 49.e1 - 6.

102. Li C., Miao J.K., Xu Y., Hua Y.Y., Ma Q., Zhou L.L., et al. Prenatal, perinatal and neonatal risk factors for perinatal arterial ischaemic stroke: a systematic review and meta-analysis. Eur J Neurol. 2017; 24(8): 1006-15.

103. Greenwell E.A., Wyshak G., Ringer S.A., Johnson L.C., Rivkin M.J., Lieberman E. Intrapartum temperature elevation, epidural use, and adverse outcome in term infants. Pediatrics. 2012; 129(2): e447-54.

104. Johnson C.T., Adami R.R., Farzin A. Antibiotic therapy for chorioamnionitis to reduce the global burden of associated disease. Front Pharmacol. 2017; 8(MAR): 1 - 6.

105. Hastings-Tolsma M., Bernard R., Brody M.G., Hensley J., Koschoreck K., Patterson E. Chorioamnionitis: Prevention and management. MCN Am J Matem Nurs. 2013; 38(4): 206-12.

106. Nitsche J.F., Patil A.S., Langman L.J., Penn H.J., Derleth D., Watson W.J., et al. Transplacental Passage of Acetaminophen in Term Pregnancy. Am J Perinatol. 2017; 34(6): 541-3.

107. Kirshon B., Moise K.J.J., Wasserstrum N. Effect of acetaminophen on fetal acid-base balance in chorioamnionitis. J Reprod Med. 1989; 34(12): 955-9.

108. Holmer Pettersson P, Owall A., Jakobsson J. Early bioavailability of paracetamol after oral or intravenous administration. Acta Anaesthesiol Scand. 2004; 48(7): 867-70.

109. Conde-Agudelo A., Romero R. Antenatal magnesium sulfate for the prevention of cerebral palsy in pretenn infants less than 34 weeks' gestation: a systematic review and metaanalysis. Am J Obstet Gynecol. 2009; 200(6): 595 - 609.

110. Doyle L.W., Crowther C.A., Middleton P, Marret S., Rouse D. Magnesium sulphate for women at risk of pretenn birth for neuroprotection of the fetus. Cochrane database Syst Rev. 2009; (1):CD004661

111. Costantine M.M., Weiner S.J., Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Effects of antenatal exposure to magnesium sulfate on neuroprotection and mortality in pretenn infants: a meta-analysis. Obstet Gynecol. 2009; 114(2 Pt 1): 354-64.

112. Elimian A., Figueroa R., Spitzer A.R., Ogbum P.L., Wiencek V., Quirk J.G. Antenatal corticosteroids: are incomplete courses beneficial? Obstet Gynecol. 2003; 102(2): 352-5.

113. Chawla S., Natarajan G., Shankaran S., Pappas A., Stoll B.J., Carlo W.A., et al. Association of Neurodevelopmental Outcomes and Neonatal Morbidities of Extremely Premature Infants With Differential Exposure to Antenatal Steroids. JAMA Pediatr. 2016; 170(12): 1164-72.

114. Nonnan M., Piedvache A., Borch K., Huusom L.D., Bonamy A.-K.E., Howell E.A., et al. Association of Short Antenatal Corticosteroid Administration-to-Birth Intervals With Survival and Morbidity Among Very Preterm Infants: Results From the EPICE Cohort. JAMA Pediatr. 2017; 171 (7): 678-86.

115. Duff P., Sanders R., Gibbs R.S. The course of labor in term patients with chorioamnionitis. Am J Obstet Gynecol. 1983; 147(4): 391-5.

116. Satin A.J., Maberry M.C., Leveno K.J., Sherman M.L., Kline D.M. Chorioamnionitis: a harbinger of dystocia. Obstet Gynecol. 1992; 79(6): 913-5.

117. Mark S.P, Croughan-Minihane M.S., Kilpatrick S.J. Chorioamnionitis and uterine function. Obstet Gynecol. 2000; 95(6 Pt 1): 909-12.

118. Maberry M.C., Ramin S.M., Gilstrap L.C. 3rd, Leveno K.J., Dax J.S. Intrapartum asphyxia in pregnancies complicated by intra-amniotic infection. Obstet Gynecol. 1990; 76(3 Pt 1): 351-4.

119. Hauth J.C., Gilstrap L.C. 3rd, Hankins G.D., Connor K.D. Term maternal and neonatal complications of acute chorioamnionitis. Obstet Gynecol. 1985; 66(1): 59 - 62.

120. Sameshima H., Ikenoue T., Ikeda T., Kamitomo M., Ibara S. Association of nonreassuring fetal heart rate patterns and subsequent cerebral palsy in pregnancies with intrauterine bacterial infection. Am J Perinatol. 2005; 22(4): 181-7.

121. Galli L., Dall'Asta A., Whelehan V, Archer A., Chandraharan E. Intrapartum cardiotocography patterns observed in suspected clinical and subclinical chorioamnionitis in term fetuses. J Obstet Gynaecol Res. 2019; 45(12): 2343-50.

122. Simmons S.W., Dennis A.T., Cuna A.M., Richardson M.G., Bright M.R. Combined spinal-epidural versus spinal anaesthesia for caesarean section. Cochrane database Syst Rev. 2019; 10:CD008100.

123. Holzer I., Lehner R., Ristl R., Husslein P.W., Berger A., Farr A. Effect of delivery mode on neonatal outcome among pretenn infants: an observational study. Wien Klin Wochenschr. 2017; 129 (17 - 18): 612-7.

124. Younge N., Goldstein R.F., Bann C.M., Hintz S.R., Patel R.M., Smith P.B., et al. Survival and Neurodevelopmental Outcomes among Periviable Infants. N Engl J Med. 2017; 376(7): 617-28.

125. Bergenhenegouwen L.A., Meertens L.J.E., Schaaf J., Nijhuis J.G., Mol B.W., Kok M., et al. Vaginal delivery versus caesarean section in preterm breech delivery: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2014; 172: 1 - 6.

126. No Title. Geneva; 2015.

127. Grabovac M., Karim J.N., Isayama T., Liyanage S.K., McDonald S.D. What is the safest mode of birth for extremely preterm breech singleton infants who are actively resuscitated? A systematic review and meta-analyses. BJOG. 2018; 125(6): 652-63.

128. Leek BF, McDonald D V.J. The spontaneous motility of human myometrial strips in vitro and its modification by some bacterial extracts. J Physiol. 1982; 324:42.

129. Smaill F. Intrapartum antibiotics for group B streptococcal colonisation. Cochrane database Syst Rev. 2000; (2):CD000115.

130. Benitz W.E., Gould J.B., Druzin M.L. Antimicrobial prevention of early-onset group B streptococcal sepsis: estimates of risk reduction based on a critical literature review. Pediatrics. 1999; 103(6): e78.

131. Ohlsson A., Shah V.S. Intrapartum antibiotics for known maternal Group B streptococcal colonization. Cochrane database Syst Rev. 2013; (1):CD007467.

132. Asbill K.K., Higgins R.V., Bahrani-Mostafavi Z., Vachris J.C., Kotrotsios S.H., Elliot M.C., et al. Detection of Neisseria gonorrhoeae and Chlamydia trachomatis colonization of the gravid cervix. Am J Obstet Gynecol. 2000; 183(2): 340-6.

133. Silver B.J., Guy R.J., Kaldor J.M., Jamil M.S., Rumbold A.R. Trichomonas vaginalis as a cause of perinatal morbidity: a systematic review and meta-analysis. Sex Transm Dis. 2014; 41(6): 369-76.

134. Heumann C.L., Quilter L.A.S., Eastment M.C., Heffron R., Hawes S.E. Adverse Birth Outcomes and Maternal Neisseria gonorrhoeae Infection: A Population-Based Cohort Study in Washington State. Sex Transm Dis. 2017; 44(5): 266-71.

135. Smaill F.M., Vazquez J.C. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane database Syst Rev. 2019; 2019(11).

136. Kenyon S., Pike K., Jones D.R., Brocklehurst P., Marlow N., Salt A., et al. Childhood outcomes after prescription of antibiotics to pregnant women with preterm rupture of the membranes: 7-year follow-up of the ORACLE I trial. Lancet (London, England). 2008; 372(9646): 1310-8.

137. Tchirikov M., Schlabritz-Loutsevitch N., Maher J., Buchmann J., Naberezhnev Y., Winamo A.S., et al. Mid-trimester preterm premature rupture of membranes (PPROM): Etiology, diagnosis, classification, international recommendations of treatment options and outcome. J Perinat Med. 2018; 46(5): 465-88.